CoChat

mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects

Open access
Joffe, Max E., Santiago, Chiaki I., Oliver, Kendra H., Maksymetz, James, Harris, Nicholas A., Engers, Julie L., Lindsley, Craig W., Winder, Danny G., Conn, P. Jeffrey · 2020 · Neuron
Cited by 76

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Summary Non-selective antagonists of metabotropic glutamate receptor subtypes 2 (mGlu2) and 3 (mGlu3) exert rapid antidepressant-like effects by enhancing prefrontal cortex (PFC) glutamate transmission, however the receptor subtype contributions and underlying mechanisms remain unclear. Here, we leveraged newly developed negative allosteric modulators (NAMs), transgenic mice, and viral-assisted optogenetics to test the hypothesis that selective inhibition of mGlu2 or mGlu3 potentiates PFC excitatory transmission and confers antidepressant efficacy in preclinical models. We found that systemic treatment with an mGlu2 or mGlu3 NAM rapidly activated biophysically unique PFC pyramidal cell ensembles. Mechanistic studies revealed that mGlu2 and mGlu3 NAMs enhance thalamocortical transmission and inhibit long-term depression by mechanistically distinct presynaptic and postsynaptic actions. Consistent with these actions, systemic treatment with either NAM decreased passive coping and reversed anhedonia in two independent chronic stress models, suggesting that both mGlu2 and mGlu3 NAMs induce antidepressant-like effects through related but divergent mechanisms of action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2019.09.044

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 52

  1. Anastasiades, 2018, Cell-type specificity of callosally evoked excitation and feedforward inhibition in the prefrontal cortex, Cell Rep., 22, 679, 10.1016/j.celrep.2017.12.073 · DOI · Paper page
  2. Anastasiades, 2019, Cell-type-specific D1 dopamine receptor modulation of projection neurons and interneurons in the prefrontal cortex, Cereb. Cortex, 29, 3224, 10.1093/cercor/bhy299 · DOI · Paper page
  3. Barth, 2004, Alteration of neuronal firing properties after in vivo experience in a FosGFP transgenic mouse, J. Neurosci., 24, 6466, 10.1523/JNEUROSCI.4737-03.2004 · DOI · Paper page
  4. Bocchio, 2019, Group II metabotropic glutamate receptors mediate presynaptic inhibition of excitatory transmission in pyramidal neurons of the human cerebral cortex, Front. Cell. Neurosci., 12, 508, 10.3389/fncel.2018.00508 · DOI
  5. Bollinger, 2017, Design and synthesis of mGlu2 NAMs with improved potency and CNS penetration based on a truncated picolinamide core, ACS Med. Chem. Lett., 8, 919, 10.1021/acsmedchemlett.7b00279 · doi:10.1021/acsmedchemlett.7b00279
  6. Caetano, 2006, Smaller cingulate volumes in unipolar depressed patients, Biol. Psychiatry, 59, 702, 10.1016/j.biopsych.2005.10.011 · DOI
  7. Chaki, 2017, mGlu2/3 receptor antagonists as novel antidepressants, Trends Pharmacol. Sci., 38, 569, 10.1016/j.tips.2017.03.008 · DOI · Paper page
  8. Collins, 2018, Reciprocal circuits linking the prefrontal cortex with dorsal and ventral thalamic nuclei, Neuron, 98, 366, 10.1016/j.neuron.2018.03.024 · DOI · Paper page
  9. Cryan, 2005, The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice, Neurosci. Biobehav. Rev., 29, 571, 10.1016/j.neubiorev.2005.03.009 · DOI · Paper page
  10. Di Menna, 2018, Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system, Neuropharmacology, 128, 301, 10.1016/j.neuropharm.2017.10.026 · DOI
  11. Dong, 2017, Rapid and sustained antidepressant action of the mGlu2/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine, Int. J. Neuropsychopharmacol., 20, 228
  12. Engers, 2015, Discovery of a selective and CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 with antidepressant and anxiolytic activity in rodents, J. Med. Chem., 58, 7485, 10.1021/acs.jmedchem.5b01005 · DOI
  13. Engers, 2017, Design and synthesis of N-aryl phenoxyethoxy pyridinones as highly selective and CNS penetrant mGlu3 NAMs, ACS Med. Chem. Lett., 8, 925, 10.1021/acsmedchemlett.7b00249 · DOI
  14. Fujioka, 2014, Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes, Mol. Brain, 7, 31, 10.1186/1756-6606-7-31 · DOI
  15. Gourley, 2009, Recapitulation and reversal of a persistent depression-like syndrome in rodents, Curr. Protoc. Neurosci. Chapter 9, 10.1002/0471142301.ns0932s49 · DOI · Paper page
  16. Gourley, 2008, Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone, Biol. Psychiatry, 64, 884, 10.1016/j.biopsych.2008.06.016 · DOI · Paper page
  17. Harris, 2018, Dorsal BNST α2A-adrenergic receptors produce HCN-dependent excitatory actions that initiate anxiogenic behaviors, J. Neurosci., 38, 8922, 10.1523/JNEUROSCI.0963-18.2018 · DOI
  18. Hetzenauer, 2008, Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism, Psychopharmacology (Berl.), 201, 1, 10.1007/s00213-008-1236-2 · DOI
  19. Highland, 2019, Group II metabotropic glutamate receptor blockade promotes stress resilience in mice, Neuropsychopharmacology, 44, 1788, 10.1038/s41386-019-0380-1 · DOI
  20. Jin, 2018, mGluR2 versus mGluR3 metabotropic glutamate receptors in primate dorsolateral prefrontal cortex: postsynaptic mGluR3 strengthen working memory networks, Cereb. Cortex, 28, 974, 10.1093/cercor/bhx005 · DOI · Paper page
  21. Joffe, 2019, Antidepressant potential of metabotropic glutamate receptor mGlu2 and mGlu3 negative allosteric modulators, Neuropsychopharmacology, 44, 214, 10.1038/s41386-018-0192-8 · DOI
  22. Joffe, 2016, Cocaine experience enhances thalamo-accumbens N-methyl-D-aspartate receptor function, Biol. Psychiatry, 80, 671, 10.1016/j.biopsych.2016.04.002 · DOI
  23. Joffe, 2017, GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation, Neuropharmacology, 112, 172, 10.1016/j.neuropharm.2016.03.026 · DOI
  24. Joffe, 2018, Metabotropic glutamate receptors in alcohol use disorder: physiology, plasticity, and promising pharmacotherapies, ACS Chem. Neurosci., 9, 2188, 10.1021/acschemneuro.8b00200 · DOI
  25. Joffe, 2019, Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function, Mol. Psychiatry, 24, 916, 10.1038/s41380-017-0015-z · DOI
  26. Joffe, 2019, Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress, Neuropharmacology, 144, 19, 10.1016/j.neuropharm.2018.10.013 · DOI
  27. Johnson, 2017, Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum, Neuropharmacology, 117, 114, 10.1016/j.neuropharm.2017.01.038 · DOI
  28. Kiritoshi, 2015, Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex, Neuropharmacology, 95, 388, 10.1016/j.neuropharm.2015.04.003 · DOI
  29. Koike, 2013, Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression, Behav. Brain Res., 238, 48, 10.1016/j.bbr.2012.10.023 · DOI
  30. Krystal, 2013, Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond, Biol. Psychiatry, 73, 1133, 10.1016/j.biopsych.2013.03.026 · DOI · Paper page
  31. Kupferschmidt, 2015, Brain BLAQ: Post-hoc thick-section histochemistry for localizing optogenetic constructs in neurons and their distal terminals, Front. Neuroanat., 9, 6, 10.3389/fnana.2015.00006 · DOI
  32. Lahti, 2001, Effects of ketamine in normal and schizophrenic volunteers, Neuropsychopharmacology, 25, 455, 10.1016/S0893-133X(01)00243-3 · DOI · Paper page
  33. Linden, 2005, Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo, Neuropharmacology, 49, 120, 10.1016/j.neuropharm.2005.05.006 · DOI
  34. Linden, 2009, Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495, Neuropharmacology, 57, 172, 10.1016/j.neuropharm.2009.05.002 · DOI
  35. Lipowski, 1987, Delirium (acute confusional states), JAMA, 258, 1789, 10.1001/jama.1987.03400130103041 · DOI · Paper page
  36. Lourenço Neto, 2000, Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat, Brain Res., 854, 93, 10.1016/S0006-8993(99)02326-4 · DOI
  37. Marek, 2000, Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex, J. Pharmacol. Exp. Ther., 292, 76, 10.1016/S0022-3565(24)35262-0 · DOI · Paper page
  38. Marek, 2001, A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex, Neuroscience, 105, 379, 10.1016/S0306-4522(01)00199-3 · DOI · Paper page
  39. Miller, 2017, Synaptic regulation of a thalamocortical circuit controls depression-related behavior, Cell Rep., 20, 1867, 10.1016/j.celrep.2017.08.002 · DOI · Paper page
  40. Moghaddam, 1998, Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats, Science, 281, 1349, 10.1126/science.281.5381.1349 · DOI · Paper page
  41. Nicoletti, 2019, Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia, Front. Psychiatry, 10, 49, 10.3389/fpsyt.2019.00049 · DOI
  42. Ohishi, 1993, Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat, Neuroscience, 53, 1009, 10.1016/0306-4522(93)90485-X · DOI · Paper page
  43. Ohishi, 1993, Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study, J. Comp. Neurol., 335, 252, 10.1002/cne.903350209 · DOI · Paper page
  44. Rajkowska, 2000, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol. Psychiatry, 48, 766, 10.1016/S0006-3223(00)00950-1 · DOI · Paper page
  45. Solich, 2008, Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter, Pharmacol. Rep., 60, 1008
  46. Sturm, 2015, Effect of chronic corticosterone application on depression-like behavior in C57BL/6N and C57BL/6J mice, Genes Brain Behav., 14, 292, 10.1111/gbb.12208 · DOI · Paper page
  47. Thuault, 2013, Prefrontal cortex HCN1 channels enable intrinsic persistent neural firing and executive memory function, J. Neurosci., 33, 13583, 10.1523/JNEUROSCI.2427-12.2013 · DOI · Paper page
  48. Vardy, 2015, A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior, Neuron, 86, 936, 10.1016/j.neuron.2015.03.065 · DOI · Paper page
  49. Walker, 2015, Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction, Proc. Natl. Acad. Sci. USA, 112, 1196, 10.1073/pnas.1416196112 · DOI · Paper page
  50. Witkin, 2017, Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects, Pharmacol. Biochem. Behav., 155, 43, 10.1016/j.pbb.2017.03.001 · DOI
  51. Woolley, 2008, The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity, Psychopharmacology (Berl.), 196, 431, 10.1007/s00213-007-0974-x · DOI · Paper page
  52. Yuen, 2012, Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex, Neuron, 73, 962, 10.1016/j.neuron.2011.12.033 · DOI · Paper page

Cited by

See all 76

Metadata

Authors
Joffe, M. E., Santiago, C. I., Oliver, K. H., Maksymetz, J., Harris, N. A., Engers, J. L., Lindsley, C. W., Winder, D. G., & Conn, P. J.
Venue
Neuron
Publisher
Elsevier BV
Published
2020-01
Volume
105
Issue
1
Pages
46-59.e3
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2946585706
Cited by
76
References
25
FWCI
6.40
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • National Institutes of Health
  • Pharmaceutical Research and Manufacturers of America Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects. https://app.cochat.ai/papers/10.1016/j.neuron.2019.09.044
The paper
Joffe, M. E., Santiago, C. I., Oliver, K. H., Maksymetz, J., Harris, N. A., Engers, J. L., Lindsley, C. W., Winder, D. G., & Conn, P. J. (2020). mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects. Neuron. https://doi.org/10.1016/j.neuron.2019.09.044

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.